Treating neurocysticercosis (NCC), an infection of the brain with tapeworm larvae, often leads to inflammation and seizures when the parasites in the brain die. Now, researchers have reported that pretreatment with the anti-tumor necrosis factor drug etanercept (ETN) is a viable strategy to manage this post-treatment inflammation.